Quarterly report pursuant to Section 13 or 15(d)

SHARE-BASED COMPENSATION

v3.23.1
SHARE-BASED COMPENSATION
3 Months Ended
Mar. 31, 2023
STOCK-BASED COMPENSATION  
STOCK-BASED COMPENSATION

8. SHARE-BASED COMPENSATION

Performance-Based Shares. In April 2023, the Compensation Committee approved the satisfaction of certain performance criteria related to our operations in 2022. Such performance measures involved multi-year growth rates for EBITDA and free cash flow per share. As a result, a total of 75,796 shares will vest upon the later of (a) such approval by the Compensation Committee or (b) the anniversary date of their grant.

In January 2023, the Company issued a total of 40,541 performance-based shares to the Company’s CEO under the terms of his employment agreement. The vesting for these performance-based shares is based on the compounded annual growth rate of the Company’s Adjusted EBITDA and Free Cash Flow Per Share, as defined, for the three-year periods ending December 31, 2023, December 31, 2024, and December 31, 2025. For the 2023 period, one-sixth of such performance-based shares will vest on the anniversary date of the award if the Company’s annual Adjusted EBITDA for 2023 reflects at least 10% per annum growth since 2020, and one-sixth of such performance-based shares will vest on the anniversary date if the Company’s annual Free Cash Flow Per Share for 2023 reflects at least 12% per annum growth since 2020. Vesting of the performance-based shares is similar for the 2024 and 2025 periods.

As of March 31, 2023, the Company had 1,069,977 share-based awards authorized by shareholders and available for grant from the Company’s 2015 Equity Incentive Plan.

The following table summarizes information related to the Company’s common stock options as of March 31, 2023:

    

    

Weighted

Number

Average

of Stock

Exercise

Options

Price

Options outstanding at January 1, 2023

 

3,503,235

$

2.80

Granted

 

62,578

 

7.40

Exercised

 

(3,962)

 

1.51

Canceled/Forfeited

 

 

Expired

 

 

Options outstanding at March 31, 2023

 

3,561,851

$

2.88

Options exercisable at March 31, 2023

 

2,884,615

$

1.99

Components of compensation expense are as follows:

(In thousands)

Three Months Ended

March 31, 

Compensation Expense

2023

2022

Stock options

$

330

$

218

Restricted and performance-based shares

 

418

 

125

$

748

$

343

As of March 31, 2023, there was approximately $2.0 million of unrecognized compensation cost related to unvested stock options previously granted that is expected to be recognized over a weighted-average period of approximately 1.8 years. As of such date, there was also $1.2 million of unrecognized compensation cost related to unvested restricted and performance shares, which is expected to be recognized over a weighted-average period of 1.5 years.